Ken Griffin Citadel Advisors
Ken Griffin founded Citadel, one of the world’s largest and most successful hedge funds. Starting his trading career from his Harvard dorm room at a young age, Griffin quickly developed a keen sense for markets and built Citadel into a global powerhouse with billions in assets under management. Known for his quantitative and technology-driven strategies, Griffin has also made headlines for significant philanthropic contributions, supporting causes in education, the arts, and public institutions. Over the years, he has earned recognition as one of the preeminent figures in modern finance.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Meta Platforms (Facebook)
META
|
+$772M |
| 2 |
Eli Lilly
LLY
|
+$337M |
| 3 |
lululemon athletica
LULU
|
+$301M |
| 4 |
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
|
+$297M |
| 5 |
ResMed
RMD
|
+$273M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$576M |
| 2 |
AT&T
T
|
+$476M |
| 3 |
PNC Financial Services
PNC
|
+$393M |
| 4 |
Fortive
FTV
|
+$389M |
| 5 |
Accenture
ACN
|
+$374M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 2.83% |
| 2 | Technology | 2.79% |
| 3 | Financials | 2.29% |
| 4 | Consumer Discretionary | 1.93% |
| 5 | Industrials | 1.63% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
IBDN
7726
DELISTED
iShares iBonds Dec 2022 Term Corporate ETF
IBDN
| $713K | ﹤0.01% |
28,524
-118,673
| -81% | -$2.97M |
|
7727
CALL
Fortuna Silver Mines
FSM
$3.11B
| $712K | ﹤0.01% |
250,800
+50,200
| +25% | +$175K |
|
7728
CALL
Vanguard Morningstar Mega Cap Value ETF
MGV
$13.7B
| $712K | ﹤0.01% |
7,400
-2,900
| -28% | -$297K |
|
7729
PUT
2x Long VIX Futures ETF
UVIX
$217M
| $712K | ﹤0.01% |
+4
| New | +$745K |
|
|
LOGC
7730
PUT
DELISTED
ContextLogic
LOGC
| $712K | ﹤0.01% |
14,837
-4,963
| -25% | -$269K |
|
7731
PUT
Revvity
RVTY
$12.8B
| $711K | ﹤0.01% |
5,000
-25,900
| -84% | -$3.88M |
|
|
FIRY
7732
Firy Inc
FIRY
$160M
| $711K | ﹤0.01% |
28,669
+13,067
| +84% | +$510K |
|
7733
Protara Therapeutics
TARA
$233M
| $711K | ﹤0.01% |
242,571
-163,677
| -40% | -$599K |
|
7734
Cabot Corp
CBT
$4.35B
| $710K | ﹤0.01% |
+11,128
| New | +$761K |
|
|
CMPS
7735
PUT
Compass Pathways
CMPS
$1.92B
| $710K | ﹤0.01% |
65,600
-129,600
| -66% | -$1.31M |
|
7736
Matthews International
MATW
$703M
| $710K | ﹤0.01% |
24,778
-30,930
| -56% | -$945K |
|
|
ONL
7737
Orion Office REIT
ONL
$161M
| $710K | ﹤0.01% |
64,776
-14,565
| -18% | -$188K |
|
|
TGI
7738
PUT
DELISTED
Triumph Group
TGI
| $710K | ﹤0.01% |
53,400
+31,500
| +144% | +$597K |
|
7739
CALL
Westlake Chemical Partners
WLKP
$763M
| $710K | ﹤0.01% |
28,500
+17,900
| +169% | +$479K |
|
7740
CALL
The Greenbrier Companies
GBX
$1.4B
| $709K | ﹤0.01% |
19,700
-39,800
| -67% | -$1.66M |
|
|
JNPR
7741
DELISTED
Juniper Networks
JNPR
| $709K | ﹤0.01% |
24,853
-82,275
| -77% | -$2.6M |
|
7742
Southern First Bancshares
SFST
$608M
| $709K | ﹤0.01% |
16,264
+10,990
| +208% | +$499K |
|
|
CUK
7743
CALL
DELISTED
Carnival PLC
CUK
| $708K | ﹤0.01% |
89,600
+45,600
| +104% | +$616K |
|
7744
iShares Asia/Pacific Dividend ETF
DVYA
$71.8M
| $708K | ﹤0.01% |
21,364
+3,280
| +18% | +$118K |
|
7745
Evolution Petroleum
EPM
$137M
| $708K | ﹤0.01% |
129,647
-31,976
| -20% | -$215K |
|
7746
CALL
Immunic
IMUX
$223M
| $708K | ﹤0.01% |
20,410
+11,750
| +136% | +$753K |
|
7747
Tortoise North American Pipeline ETF
TPYP
$897M
| $708K | ﹤0.01% |
29,203
-66,332
| -69% | -$1.75M |
|
7748
CALL
Global Partners
GLP
$1.73B
| $707K | ﹤0.01% |
30,100
+13,600
| +82% | +$361K |
|
|
CFB
7749
DELISTED
CrossFirst Bankshares, Inc. Common Stock
CFB
| $707K | ﹤0.01% |
+53,493
| New | +$721K |
|
7750
Fidelity D&D Bancorp
FDBC
$318M
| $706K | ﹤0.01% |
17,360
+12,242
| +239% | +$478K |
|
Similar funds
Ken Griffin's Q2 2022 Portfolio in Review
As of Q2 2022, Ken Griffin held 14,957 positions worth $390B, down 20% from $484B the previous quarter. Its ten largest holdings account for 28% of the portfolio.
Ken Griffin's Q2 2022 filing shows 1,520 new, 5,503 increased, 5,522 reduced and 2,191 closed positions. Its largest new stake was ResMed: 1,280,595 shares worth $268M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $576M.
By sector, the portfolio is most concentrated in Healthcare at 2.8% of assets, up from 2.4% a quarter earlier, followed by Technology and Financials.
- Ken Griffin's largest Q2 2022 buy was ResMed: 1,280,595 shares worth $268M.
- Ken Griffin added most to Meta Platforms (Facebook) in Q2 2022, an estimated $772M increase.
- Ken Griffin's biggest Q2 2022 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $576M.
- Ken Griffin fully exited Vanguard Morningstar Small-Cap ETF in Q2 2022, selling an estimated $184M.
- Ken Griffin's ten largest holdings make up 28% of its $390B portfolio in Q2 2022.
- Ken Griffin opened 1,520 new positions and closed 2,191 in Q2 2022.
- Ken Griffin's portfolio value fell 20% quarter-over-quarter to $390B.
Based on Citadel Advisors's 13F filing for Q2 2022, filed 15 Aug 2022.